Monitor for potential follow-on selling or absence of buying ahead of next earnings. The divergence between cash selling and non-cash grants may signal lack of conviction despite equity compensation.
Price Chart
Executive Summary
Multiple C-suite executives at Vir Biotechnology, including the CEO, CFO, and General Counsel, conducted open-market share sales over the past week, totaling $404,942 in sales proceeds. These transactions coincide with a routine grant of stock awards worth $0 in value. The selling represents modest insider divestment by top executives.
Key Financial Metrics
Key Facts
- CEO Marianne De Backer sold 33,801 shares for $282,614 in open-market transactions.
- CFO Jason O'Byrne and General Counsel Vanina de Verneuil each sold 2,089 and 21,262 shares, respectively, netting $15,569 and $197,375 total.
- Five C-suite insiders sold shares in open market, aggregating $404,942 in total proceeds.
- All sales occurred between $7.45 and $9.82 per share, with higher prices on later dates.
- On the same day as the sales began, the company granted non-cash stock awards totaling 420,000 shares to these insiders, which do not represent economic buying interest.
Financial Impact
$404,942 in open-market insider selling over 7 days
Risk Factors
- Perception of insider pessimism, especially from CEO and CFO selling material amounts.
- Potential downward pressure on shares if selling continues or is interpreted as negative signal.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (13 trades, 7d window) | cluster-VIR-1772142904713 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 14, 2026 7w ago | Court Ruling | $9.24 $9.78 | ▲ +5.84% | ▲ +7.21% | $11.17 (+20.89%) |
Aug 9, 2026 7w ago | Institutional Cluster | $8.89 $9.39 | ▲ +5.62% | ▲ +5.67% | $11.17 (+25.65%) |
Jul 24, 2026 10w ago | 8-K | $8.69 $8.90 | ▲ +2.42% | ▲ +2.04% | $11.17 (+28.54%) |
Jun 29, 2026 13w ago | 144 | $10.38 $10.02 | ▼ −3.47% | ▼ −4.86% | $11.17 (+7.61%) |
Jun 10, 2026 16w ago | 3 | $8.52 $9.30 | ▲ +9.15% | ▲ +8.72% | $11.17 (+31.10%) |
Jun 10, 2026 16w ago | 8-K | $8.52 $9.30 | ▲ +9.15% | ▲ +8.72% | $11.17 (+31.10%) |
Jun 2, 2026 17w ago | Insider Cluster | $8.77 $8.25 | ▼ −5.93% | ▼ −2.11% | $11.17 (+27.37%) |
May 28, 2026 18w ago | 8-K | $9.55 $8.77 | ▼ −8.17% | ▼ −8.12% | $11.17 (+16.96%) |
Apr 16, 2026 24w ago | DEFA14A | $10.33 $10.35 | ▲ +0.19% | ▼ −0.79% | $11.17 (+8.13%) |
Apr 10, 2026 25w ago | 8-K | $9.31 $11.09 | ▲ +19.12% | ▲ +15.82% | $11.17 (+19.98%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access